IRCT2014050612206N1已完成4 期
Population Pharmacokinetics study of Imatinib in CML patients
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •patients with CML in chronic phase who take Imatinib from diagnosis and have no other disease.
排除标准
- •taking Interfron or Hydroxyurea in past or during the study; taking drugs that induce or inhibit liver microsomal enzymes and patients in accelerated or blastic phases.
研究者
相似试验
尚未招募
不适用
Personalized Treatment for Blood CancerCTRI/2019/10/021533R Saravanabhavan
已完成
不适用
Imatinib pharmacokinetics and its correlation with response in chronic-phase chronic myelogenous leukemiachronic myelogenous leukemia in chronic-phaseJPRN-UMIN000001125Keio University School of Medicine60
招募中
不适用
Imatinib pharmacokinetics and its correlation with response and safety in Indian children and adults with chronic phase chronic myeloid leukemia.CTRI/2010/091/000190Terry Fox Fooundation150
已完成
不适用
A Randomized Phase Lll Study of Imatinib Dose Optimization Compared With Nilotinib in Patients With Chronic Myelogenous Leukemia and Suboptimal Response to Standard-dose ImatinibPER-023-09OVARTIS BIOSCIENSES PERU S.A.,
进行中（未招募）
不适用
An exploratory study of the effects of Imatinib on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen – an exploratory study of c-kit inhibition in allergic respiratory diseasesSeasonal Allergic Rhinitis (sensitivity to Timothy grass pollen)MedDRA version: 8.1Level: LLTClassification code 10039776Term: Seasonal allergic rhinitisEUCTR2006-004722-82-GBovartis Pharma Services AG30